Kratom is a popular herb derived from Mitragyna speciosa, an evergreen tree native to the tropical rainforests of Southeast Asia. First discovered by Westerners in the nineteenth century, kratom has been embraced by millions of users around the world.
Here in the U.S., kratom is made available in a variety of forms from micronized kratom powder and kratom capsules to kratom extract, kratom resin and homemade kratom soaps. Although kratom use is very much in vogue, the FDA has not approved this substance for medicinal use and it has become the subject of much debate among lawmakers who question its safety.
Table of Contents
Kratom has been banned in Canada, Finland, Korea, Russia, Switzerland and the United Kingdom, among others. The first country to outlaw the planting or possession of the Mitragyna speciosa plant was Thailand.
The issue of legality is largely due to a rash of kratom-related hospitalizations, most of which have been linked to preexisting conditions or prescription drug interactions. A 2018 Salmonella outbreak led the FDA to issue a mandatory recall on select kratom products.
These incidents resulted in increased pressure from the FDA to institute a kratom ban. However, such a ban was postponed after they opened the issue up to public comment and received an overwhelming number of responses from American citizens who attested to the herb’s many benefits, perceived or otherwise.
As it happens, efforts to curtail kratom use wasn’t always a matter of keeping the public safe. Kratom was originally indigenous to Thailand where its use became so widespread that it threatened the opium trade. The Thai government decided to enact a nationwide kratom ban in an attempt to quell kratom use and encourage opium sales.
Today there are many individuals who are actively advocating for the Thai kratom ban to be lifted. Alas, there are also many lawmakers here in the United States who seek to criminalize this Ayurvedic herb.
Thus far, kratom has been outlawed or otherwise restricted in six states—Alabama, Arkansas, Indiana, Rhode Island, Vermont and Wisconsin, respectively. It has also been banned in the city of San Diego, CA as well as Sarasota County, FL and Union County, Mississippi.
Kratom remains legal in the state of Colorado, but “human consumption” of kratom is illegal in Denver. In New Hampshire, kratom users must be 18 years of age in order to purchase the substance in any form. In Tennessee, a kratom ban has been lifted and sale of kratom is now legal to individuals 21 years of age or older.
Due to the gray legal area that kratom occupies, manufacturers are unable to offer this compound in public shops. E-commerce sites like Kraken Kratom, Kratom Crazy, Mitragaia and Urban Ice Organics are among those businesses which currently provide kratom to online consumers.
In countries where Mitragyna speciosa is legal the government nevertheless seeks to subjugate the import and export of this prized herb. The DEA has frequently seized kratom shipments from kratom vendors’ partners in Indonesia and beyond.
All of this precarious business makes kratom a high risk prospect for public trading firms and the like. When a company wants to be listed on the stock exchange, they are expected to disclose a wealth of pertinent information. Since the scientific evidence supporting kratom’s effects is largely considered inconclusive, this poses a problem for those who want to offer kratom stocks.
This lack of information has prevented companies from displaying their product on the market. Furthermore, kratom’s status as a prohibited substance in some countries has discouraged manufacturers from being listed.
The consequence of offering kratom stock would be quite severe given the criminal codification of the herb. As a compound that is scheduled as a controlled substance in some parts and an illegal substance in others, it would be against the law for shareholders in kratom companies to sell their shares publicly.
If such shares were offered to the public and the person or persons responsible were discovered they would face arrest and potential imprisonment for their crime. This is unfortunate given the lucrative nature of the kratom industry, but it would be ill-advised for any shareowner to attempt such malfeasance.
As of this writing, there are more than five million estimated kratom users in the global marketplace. Sales continue to mushroom with approximately $1 billion in revenue trickling in from all over the globe.
I know that it might seem like a long shot, but it isn’t really that hard to imagine a future in which companies could begin to offer stock in their operations. Over the last few years, we have seen a number of extreme penny stocks soar to levels of success that few could have predicted.
Financial analysts have long urged the public to avoid penny stocks, but micro-cap companies have managed to revamp the penny stock’s image. In 2020, the market would seem to be in serious flux, but those on the floor have seen the tremendous upside potential of penny stocks.
These individuals recognize market cap stock as the kind of thing that can weather the storm of public panic and it’s easy to see why this could be the case for kratom penny stocks as much as any other one. Given the fungible nature of stocks in general, kratom stocks could hypothetically replace hemp CBD stocks in the year ahead.
As non-profit organizations such as the AKA (American Kratom Association) attempt to educate legislators about the extant data supporting the herb’s palliative value, it isn’t a stretch to imagine that the laws may change in kratom’s favor. The natural result would be the public trading of kratom penny stocks.
One area that these stocks could be applied to would be the increasingly profitable presence of kava bars in the United States and elsewhere. Many kava bars sell both kava kava and kratom drinks. These ethnobotanical cocktail lounges have become quite fashionable in the Aughts with hipsters and young professionals flocking to their vibrant locations for an alternative to the traditional nightlife atmosphere.
Kava sales have yielded more than $200 million annually for the South Pacific region alone. With approximately 100 U.S.-based kava bars currently in operation, it is clear that this is a remunerative economic activity.
Should kratom stocks be made available in the long run, users should be apprised of the best method by which to invest. It’s far simpler than you might initially suspect.
Penny stock trading thrives because it is cheap. There is minimal cost to buy in and you can cash out with quite the bundle, so to speak. For instance, you can buy 10,000 shares of a $0.30 stock for $3,000 and if the stock rises to $1 per share, you’ve made seven grand, therefore doubling your investment.
By keeping your investments small, you mitigate any potential disasters that may arise. For example, I have always believed in investing no more than you would spend on a meal at a fast food restaurant. In other words, I calculate how much I spend annually on fast food and invest that same dollar amount in penny stocks.
If the stock reaches a substantial high I’ve turned a profit with minimal monetary discomfort. If the stock plummets, I have lost no more than the average person spends on scratchy lottery tickets or Big Macs.
For starters, you will not be able to buy kratom stocks any time soon. For now we must wait and see how things shake out on the national stage. As a presidential election looms on the horizon, we may see kratom exploited as part of a candidate’s agenda. This could spell good news for kratom or bad news. Which one it will be is anyone’s guess.
If you are considering an investment in CBD stocks, you will want to do a fair amount of research. Once you have narrowed your search down to a handful of prospects you will want to be mindful of the small print.
Companies that offer penny stocks are extremely fond of protecting their butts by way of vague legalese. They will hide everything you need to know in small and strategically placed disclaimers. They do so because they take for granted that the average consumer will not bother to read such a disclaimer (think of all the Terms and Conditions you’ve blindly agreed to when installing apps on your iPhone and you get the idea).
Rule # 1: Read, re-read and re-re-read those disclaimers. You’ll find in them everything you need to know about the very real risks associated with the penny stocks in question.
Rule # 2: Avoid stock tips. They’re worth less than…well, a penny stock. Those issuing stock tips are those in the business of making money off the public’s greatest expectations. The better something sounds, the crappier it likely is.
Rule # 3: Seek the Secret. No, I’m not talking about that self-help book everyone and their mother was reading at the turn of the century. I’m referring to those stocks that aren’t shoved in your face by every firm on the market. It’s an open secret that companies horde the best for themselves and only ever offer the truly lucrative opportunities to their wealthiest clients. If you find out about a name that you haven’t heard of before, you may have struck pay dirt.
Rule # 4: Don’t waste time. You should sell fast when opportunity knocks. Hesitation will get you nowhere.
Rule # 5: Manage your expectations. The probability of getting rich overnight is astronomical, but paying off your mortgage might not be. Always remember to keep things in perspective. Everything is fungible…even your savings.
We back all of our products with a full MONEY-BACK GUARANTEE so that you can order risk-free